摘要
目的探析护肝解纤汤对肝硬化患者的护肝作用的临床疗效及可能的作用机制。方法将我院收治的38例肝硬化患者按照随机分组的原则,分为治疗组和对照组。对照组给予常规治疗,治疗组在对照组的基础上给予护肝解纤汤的处方治疗,按照5个月为1疗程,然后进行临床疗效的评价。结果护肝解纤汤组较对照组均具有明显的抗肝纤维化的作用,两组进行比较存在显著性差异(P<0.05)。结论护肝解纤汤治疗肝硬化的临床疗效显著,安全有效,可作为临床推广应用。
Objective Analysis solutions that Huganjiexian decoction protect liver function in patients with hepatic cirrhosis clinical effect and possible mechanism of action. Methods To our hospital of 38 cases of patients with hepatic cirrhosis, according to the principle of random grouping, divided into treatment group and control group.Control group given conventional treatment, the treatment group in the control group on the basis of the given solutions that Huganjiexian decoction prescription treatment, according to the five months for a period of treatment, and evaluate clinical effect. Results Compared with Huganjiexian decoction group than the control group has obvious effect of liver fibrosis, comparing two groups exist significant difference （P〈0.05）.Conclusion Huganjiexian decoction treatment of the clinical effect of hepatic cirrhosis, safe and effective, and can be used as a clinical application.
出处
《中国卫生产业》
2014年第31期20-21,共2页
China Health Industry
关键词
护肝解纤汤
肝硬化
临床应用
Huganjiexian decoction
Hepatic cirrhosis
Clinical application
